コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 -treat analysis, inhaled corticosteroid adherence was 25.4% higher in the intervention group than in the usual care group
2 weeks, CD4 cell percentage was 2.88% (95% CI, 1.26%-4.49%) higher in the efavirenz group than in the ritonavir-boosted l
3 free and relapse-free survival at 2 years was significantly higher in the ATG group than in the non-ATG group (36.6% vs.
4 Clinically significant improvement in FCR was significantly higher in the bCBT group than in the CAU group (13 [29%] of 4
5 thin 12 weeks after treatment initiation were significantly higher in the blinatumomab group than in the chemotherapy gro
6 ating disorder psychopathologic findings were significantly higher in the CBT group than in the GSH-I group at 6-month fo
7 nd line, median (IQR) nutrient densities were significantly higher in the CFR group than in the non-CFR group for iron [i
8 hat the rate of progression-free survival was significantly higher in the daratumumab group than in the control group; th
9 Dendritic cell density was significantly higher in the DED group than in the controls (111.7 +/- 137.3
10 The response rate was significantly higher in the ECT group than in the group that received algor
11 t and Toddler Development, Third Edition, was significantly higher in the EF group than in the SF group (105.8 +/- 9.2 co
12 parisons, the risk of the primary outcome was significantly higher in the femoral group than in the subclavian group (haz
13 In-hospital deaths were significantly higher in the hypoalbuminemic group than in the non-hypoalbum
14 The overall response rate was significantly higher in the ibrutinib group than in the ofatumumab group (4
15 nce at the first session of an SSS course was significantly higher in the intervention group than in the control group (4
16 birth attendants' mean practice adherence was significantly higher in the intervention group than in the control group (7
17 roups 1 month postoperatively, which remained significantly higher in the LASIK group than in the SMILE group 6 months af
18 Antibiotic usage prior to sampling was significantly higher in the LRTI group than in the control group (19 versus
19 nce of new or increased vaginal discharge was significantly higher in the pessary group than in the control group.
20 The incidence of adverse events was significantly higher in the pregabalin group than in the placebo group.
21 The rate of grade 3 or 4 neutropenia was significantly higher in the transplantation group than in the RVD-alone gro
22 ficantly decreased and the MMP2 and MMP9 were significantly higher in the VD group than in the placebo group.
23 The rate of disease-free survival was slightly higher in the dissection group than in the observation group
24 ire cohort, the long-term (3.4 +/- 1.6 years) MACE rate was higher in the ACS group than in the SIHD group (23% vs. 11%,
25 The incidence of grade 2-3 hypertension was higher in the cediranib group than in the control group (11 [
27 The percentage of patients with disability at 10 weeks was higher in the dexamethasone group than in the placebo group,
28 idence from a single study showed that the relapse rate was higher in the INFbeta group than in the GA group (risk ratio
29 onal independence (modified Rankin scale score, 0 to 2) was higher in the intervention group than in the control group (6
32 The median GPe firing frequency was higher in the NBIA group than in the secondary static group (
33 of 37 [0%]), and the likelihood of event-free survival was higher in the nusinersen group than in the control group (haz
34 The likelihood of overall survival was higher in the nusinersen group than in the control group (haz
35 The median GPi firing frequency was higher in the primary group than in the secondary static grou
36 severe recurrence of mitral regurgitation at 12 months was higher in the repair group than in the replacement group (32.
37 of moderate or severe mitral regurgitation over 2 years was higher in the repair group than in the replacement group (58.
38 usted analysis, the rate of overall survival at 4 years was higher in the rituximab group than in the observation group (
41 The rate of diabetic ketoacidosis was higher in the sotagliflozin group than in the placebo group (
42 The percentage of patients with a complete response was higher in the transplantation group than in the RVD-alone gro
43 hoalveolar lavage cells from both groups and responses were higher in the aerosol group than in the intradermal group.
44 Geometric mean levels of several PCB congeners were higher in the ASD group than in the ID and GP groups.
45 the amount of bleeding was greater, and surgical costs were higher in the fusion group than in the decompression-alone gr
47 nd major adverse cardiac events rates during follow-up were higher in the MGuard group than in the control stent group, a
48 Plasma glutamine concentrations were higher in the parenteral group than in the enteral group on p
49 Rash and photosensitivity frequencies were higher in the simeprevir group than in the placebo group (61
50 in stool acetate (P = 0.02) and total SCFAs (P = 0.05) were higher in the WG group than in the RG group.
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。